On August 13, 2024, Kathleen Waters, Chief Legal & Public Affairs Officer of DaVita Inc (NYSE:DVA), sold 7,857 shares of the company. The transaction was documented in a recent SEC filing. Following this transaction, the insider now owns 83,011 shares of DaVita Inc.
DaVita Inc specializes in kidney treatment and dialysis services and operates a network of outpatient dialysis centers. The company is known for providing a range of dialysis services, primarily for patients suffering from chronic or end-stage renal failure.
Over the past year, Kathleen Waters has sold a total of 28,936 shares and purchased no shares. This recent sale is part of a broader trend seen at DaVita Inc., where there were no insider purchases over the past year, but there were 7 insider sales.
DaVita Inc.’s stock price on the day of sale was $146.21. The company has a market capitalization of approximately $12.58 billion. DaVita Inc.’s price-to-earnings ratio is 15.97, which is below the industry median of 23.74 and also below the company’s historical median.
According to GF Value, DaVita Inc.’s intrinsic value is estimated at $115.65 per share, making the stock slightly overvalued with a price-to-value ratio of 1.26.
This insider sale could be of interest to investors who track insider behavior, especially with respect to company valuation metrics such as price-to-sales ratio, price-to-book ratio and price-to-free cash flow ratio, which are important factors in calculating GF value.
This article created by GuruFocus is intended to provide general insights and does not constitute tailored financial advice. Our commentary is based on historical data and analyst forecasts, uses an unbiased methodology and is not intended to serve as specific investment advice. It does not contain a recommendation to buy or sell any stock and does not take into account any individual investment objectives or financial circumstances. Our goal is to provide long-term, fundamental, data-driven analysis. Note that our analysis may not include the most recent, price-sensitive company announcements or qualitative information. GuruFocus does not hold a position in any stocks mentioned here.
This article first appeared on GuruFocus.
